BIOINVENT INTERNATIONAL AB
921535457ActiveClinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 1997
- Founded
Key Decision Makers
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Emma Meurling
HR Director
Nanna Lüneborg
Member of the Board
+16 more contacts in Funnelfeedr
Description
BioInvent International AB is a clinical-stage company focused on discovering and developing novel antibody therapeutics for cancer treatment. The core of their work lies in immuno-oncology, leveraging deep expertise in immunology, cancer biology, and antibody biology. They utilize their proprietary...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Utenlandsk enhet
- VAT Number
- Unknown
Decision Makers
20 contacts in FunnelfeedrCecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Emma Meurling
HR Director
Nanna Lüneborg
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
Björn Frendéus
CSO
Leonard Kruimer
Chairman of the Board
Martin Welschof
Chief Executive Officer
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Natalie Berner
Member of the Board
Laura Lassouw-Polman
Member of the Board
Bernd Seizinger
Member of the Board
Sylvie Ryckebusch
Chief Business Officer
Stefan Ericsson
Chief Financial Officer
Ashley Robinson
Senior Vice President Strategy & Finance
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Other Contacts
Marina Mangold
Data Protection Officer
Tomas Wall
Employee Representative
Elin Birgersson
Employee Representative
Similar Companies
19 similar companies in FunnelfeedrCAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Alligator Bioscience AB
10–19 employeesClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Lead Biologics International AB
1–4 employeesExpert-led life science company developing novel antibody therapeutics for cancer.
MABTECH AKTIEBOLAG
50–99 employeesDeveloping high-quality immunoassays and instruments for life science research.
Active Biotech AB (publ)
1–4 employeesDeveloping novel treatments for cancer and inflammatory eye diseases.
Browse More
BIOINVENT INTERNATIONAL AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo